Search
for
Sort by
Research 421–450 of 1000+
- Female type of adult acne: Physiological and psychological considerations and management
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Androgenic Hormone Profile of Adult Women with Acne
- Hair loss in elderly women
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Female pattern hair loss
- The Hirsute Woman: Challenges in Evaluation and Management
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- Relations between sex hormone level and characters of hair and skin in healthy young men
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome in Adolescents
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Hirsutism – From Diagnosis to Use of Antiandrogens
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Alopecia caused by isoniazid
- Healthy Skin for Women: A Review of Common Conditions and Therapies
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)